Suppr超能文献

早期食管癌食管切除术的长期结果

Long-term results of esophagectomy for early esophageal carcinoma.

作者信息

Sugimachi K, Ikebe M, Kitamura K, Toh Y, Matsuda H, Kuwano H

机构信息

Department of Surgery II, Kyushu University, Fukuoka, Japan.

出版信息

Hepatogastroenterology. 1993 Jun;40(3):203-6.

PMID:8325583
Abstract

In this paper we report on the long-term results achieved in 75 patients with superficial carcinoma of the thoracic esophagus who have been treated since 1965 with esophagectomy at our institute. In three of these patients, the carcinoma was limited to the epithelium (intra-epithelial carcinoma), while in 13 cases it was confined to the mucosa, and in 59 cases to the submucosa. There was no lymph node metastasis in patients with intra-epithelial or mucosal carcinoma, but lymph node involvement was found in 13 (22.0%) of the 59 cases of submucosal carcinoma. The five-year survival rate of patients with intra-epithelial carcinoma and mucosal carcinoma was 100%, which was significantly better than that for carcinoma invading the submucosa (49%). The five-year survival rate for patients with lymph node involvement was only 46%, which was significantly worse than that for patients without lymph node involvement (60%). No recurrence occurred in patients with intra-epithelial carcinoma or mucosal carcinoma, while recurrent disease occurred in 19 (32.2%) of the 59 patients with submucosal carcinoma. Lymph node recurrence and hematogenic recurrence such as lung and bone metastasis were the most frequent developments in patients with submucosal carcinoma of the esophagus.

摘要

本文报告了自1965年以来在我院接受食管切除术的75例胸段食管癌浅表癌患者的长期治疗结果。其中3例患者的癌局限于上皮层(上皮内癌),13例局限于黏膜层,59例局限于黏膜下层。上皮内癌或黏膜癌患者无淋巴结转移,但59例黏膜下癌患者中有13例(22.0%)出现淋巴结受累。上皮内癌和黏膜癌患者的5年生存率为100%,显著高于侵犯黏膜下层的癌(49%)。有淋巴结受累患者的5年生存率仅为46%,显著低于无淋巴结受累患者(60%)。上皮内癌或黏膜癌患者未出现复发,而59例黏膜下癌患者中有19例(32.2%)出现复发性疾病。食管黏膜下癌患者最常见的复发情况是淋巴结复发和血行转移,如肺和骨转移。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验